WASHINGTON,DC-FEBRUARY 12: An exterior of Walgreens where a security guard shot an alleged armed ... [+] robber inside the store in Chinatown, Washington, DC on February 12, 2024. (Photo by Marvin Joseph/The Washington Post via Getty Images)The Washington Post via Getty ImagesWalgreens recently reported its Q2’24 results (fiscal ends in August), with revenue and earnings exceeding the street expectations. The company reported revenue of $37.1 billion and adjusted earnings of $1.20 per share, compared to the ...

Walgreens Boots Alliance (WBA 3.19%) has been a brutal investment for the past nine years. Shares are down more than 75% from the all-time high, reached way back in early 2015. The one saving grace for investors during much of this period was the company's dividend, which the Board was still steadily increasing every year. From 2014 through late 2023, the payout was increased 40%.Well, even that's gone, with the near-halving of the dividend late last year now resulting in a payout that's 26% lower than it w ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended February 29, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From _______to _______ Commission File Number 001-36759 WALGREENS BOOTS ALLIANCE, INC. (Exact name of registrant as specified in its charter) Delaware 47-1758322 ( ...

Second Quarter Fiscal 2024 Results March 28, 2024 © 2024 Walgreens Boots Alliance, Inc. All rights reserved. Safe Harbor and Non-GAAP Cautionary Note Regarding Forward-Looking Statements: All statements in this presentation that are not historical are forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These include, without limitation, estimates of and goals for future operating, financial and tax performance and results, including ...

Exhibit 99.1 Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results Second quarter operational results in line with expectations, U.S. Healthcare achieved adjusted EBITDA profitability, narrowing full-year adjusted EPS guidance range Second quarter financial highlights • Second quarter loss per share* was $6.85 compared to earnings per share of $0.81 in the year-ago quarter; Second quarter results included a $5.8 billion after-tax non-cash impairment charge related to VillageMD goodwill • Adjus ...

CNBC's Jim Cramer on Friday guided investors through next week's most important happenings on Wall Street, saying to watch out for earnings from Walgreens as well as new data about consumer spending."We're no longer fighting the Fed, people — they don't seem inclined to raise rates when they're supposed to be cutting them, that doesn't make sense," he said. "And that means, even if we hear a lot of noise about an overheated inflation number, I'd, yes, consider it a buying opportunity."On Monday, Cramer will ...

In the latest market close, Walgreens Boots Alliance (WBA) reached $20.80, with a -1.38% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.32% for the day. Meanwhile, the Dow experienced a rise of 0.68%, and the technology-dominated Nasdaq saw an increase of 0.2%.The the stock of largest U.S. drugstore chain has fallen by 3.03% in the past month, lagging the Retail-Wholesale sector's gain of 5.25% and the S&P 500's gain of 5.11%.The investment community ...

Justin Sullivan Investment Thesis The challenges for retail pharmacy giant Walgreens Boots Alliance, Inc. (NASDAQ:WBA) are profound, with lower demand from consumers seeking vaccinations and testing for COVID-19 on one hand and tight reins on prescription drug payouts hobbling its operations. But most crucially, the company's assertive push into other healthcare businesses faces a few sticking points that show catching up might take some time. Over the past three years, Walgreens has lost nearly 60% in ...

The market expects Walgreens Boots Alliance (WBA) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended February 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on March 28, 2024, might help the stock move higher if these key ...

Walgreens Boots Alliance, Inc. (WBA) wholly-owned subsidiary — AllianceRx Walgreens Pharmacy — is selected as the exclusive distributor of Mycovia Pharmaceuticals’ VIVJOA (oteseconazole). Walgreens specialty pharmacy patients now have exclusive access to 240+ limited distribution drugs, which are available through Walgreens specialty pharmacy.The latest development will bolster Walgreens’ Speciality Pharmacy business.More on the NewsMycovia Pharmaceuticals’ VIVJOA is the first FDA-approved medicine to minim ...